Cargando…

Host Factors Dictate Control of Viral Replication in two HIV-1 Controller/Chronic Progressor Transmission Pairs

Viremic controllers (VC) and elite controllers/suppressors (ES) maintain control over HIV-1 replication. Some studies suggested that control is a result of infection with a defective viral strain while others suggested host immune factors play a key role. Here we document two HIV-1 transmission pair...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buckheit, Robert W., Allen, Tracy G., Alme, Angela, Salgado, Maria, O’Connell, Karen A., Huculak, Sarah, Falade-Nwulia, Oluwaseun, Williams, Thomas M., Gallant, Joel E., Siliciano, Robert F., Blankson, Joel N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549550/ https://www.ncbi.nlm.nih.gov/pubmed/22395607 http://dx.doi.org/10.1038/ncomms1697

Ejemplares similares

CD8(+) T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants
por: Pohlmeyer, Christopher W, et al.
Publicado: (2013)

Primary CD8(+) T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4(+) T cells
por: Buckheit, Robert W, et al.
Publicado: (2013)

Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy
por: Salgado, Maria, et al.
Publicado: (2011)

Viral suppression of multiple escape mutants by de novo CD8(+ )T cell responses in a human immunodeficiency virus-1 Infected elite suppressor
por: O'Connell, Karen A, et al.
Publicado: (2011)

Evolution of the HIV-1 nef gene in HLA-B*57 Positive Elite Suppressors
por: Salgado, Maria, et al.
Publicado: (2010)

Genotypic and Phenotypic Characterization of Replication-Competent HIV-2 Isolated from Controllers and Progressors
por: Lungu, Cynthia, et al.
Publicado: (2023)

A Human Immunodeficiency Virus Controller With a Large Population of CD4(+)CD8(+) Double-Positive T Cells
por: Durand, Christine M., et al.
Publicado: (2015)

Octogenarians with chronic kidney disease in the nephrology clinic: Progressors vs. non-progressors
por: Frías, Aida, et al.
Publicado: (2023)

Maintenance of viral suppression in HIV-1–infected HLA-B*57(+) elite suppressors despite CTL escape mutations
por: Bailey, Justin R., et al.
Publicado: (2006)

Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals
por: Weber, Jan, et al.
Publicado: (2017)

2497. Analysis of Social Determinants of Health (SDOH) and their Implications for Hepatitis C Treatment in People Who Inject Drugs: The Case of Baltimore
por: Corro, Luis A Gonzalez, et al.
Publicado: (2023)

Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors
por: El-Far, Mohamed, et al.
Publicado: (2016)

Percentage of progressors in imaging: can we ignore regressors?
por: Sepriano, Alexandre, et al.
Publicado: (2019)

2943. Hazardous Alcohol Use and Direct-acting Antiviral Therapy Initiation Among People Who Inject Drugs with Current Hepatitis C Infection
por: Karimi-Sari, Hamidreza, et al.
Publicado: (2023)

Rapid Quantification of the Latent Reservoir for HIV-1 Using a Viral Outgrowth Assay
por: Laird, Gregory M., et al.
Publicado: (2013)

Evaluation of Rapid Progressors in HIV Infection as an Extreme Phenotype
por: Olson, Ashley D., et al.
Publicado: (2014)

1590 Hepatitis C Care among HIV Infected Patients in a Community Based Clinic
por: Grier, Brittany, et al.
Publicado: (2014)

Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2013)

Are Long-Term Non-Progressors Very Slow Progressors? Insights from the Chelsea and Westminster HIV Cohort, 1988–2010
por: Mandalia, Sundhiya, et al.
Publicado: (2012)

Viral Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats during the Asymptomatic Phase
por: Eckstrand, C. D., et al.
Publicado: (2016)

The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study
por: Meijerink, Hinta, et al.
Publicado: (2014)

Array Comparative Genomic Hybridization in Ulcerative Colitis Neoplasia: Single Non-Dysplastic Biopsies Distinguish Progressors from Non-Progressors
por: Bronner, Mary P., et al.
Publicado: (2010)

Factors associated with conversion of long-term non-progressors to progressors: A prospective study of HIV perinatally infected paediatric survivors
por: Radhakrishna, Muttineni, et al.
Publicado: (2013)

HIV replication and evolution in patients on highly active antiretroviral therapy
por: Siliciano, Robert F
Publicado: (2006)

Correction: Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2014)

Elite controllers long-term non progressors present improved survival and slower disease progression
por: Capa, Laura, et al.
Publicado: (2022)

Individual and social network correlates of responding to multiple overdoses among a cohort of people who use drugs
por: Wagner, Karla D., et al.
Publicado: (2022)

HIV and HCV Activate the Inflammasome in Monocytes and Macrophages via Endosomal Toll-Like Receptors without Induction of Type 1 Interferon
por: Chattergoon, Michael A., et al.
Publicado: (2014)

TP53/p53 alterations and Aurora A expression in progressor and non-progressor colectomies from patients with longstanding ulcerative colitis
por: FRIIS-OTTESSEN, MARIANN, et al.
Publicado: (2015)

HIV-specific T-cell Responses and Generalized Activation in HIV-1 Infected Long-term Non-progressors and Progressors from South India
por: Swathirajan, Chinnambedu Ravichandran, et al.
Publicado: (2018)

Long term non-progressor (LTNP) HIV infection
por: Kumar, Praveen
Publicado: (2013)

A longitudinal study of vaccine hesitancy attitudes and social influence as predictors of COVID-19 vaccine uptake in the US
por: Latkin, Carl, et al.
Publicado: (2022)

A Randomized Controlled Trial of Cash Incentives or Peer Support to Increase HCV Treatment for Persons With HIV Who Use Drugs: The CHAMPS Study
por: Ward, Kathleen M, et al.
Publicado: (2019)

Mycobacterium tuberculosis Complex Enhances Susceptibility of CD4 T Cells to HIV through a TLR2-Mediated Pathway
por: Thayil, Seema M., et al.
Publicado: (2012)

Transcriptome Sequencing of Peripheral Blood Mononuclear Cells from Elite Controller-Long Term Non Progressors
por: Díez-Fuertes, Francisco, et al.
Publicado: (2019)

Distinct Plasma Concentrations of Acyl-CoA-Binding Protein (ACBP) in HIV Progressors and Elite Controllers
por: Isnard, Stéphane, et al.
Publicado: (2022)

Distinct antibody profiles in HLA-B(∗)57(+), HLA-B(∗)57(−) HIV controllers and chronic progressors
por: Klingler, Jéromine, et al.
Publicado: (2022)

Does B Cell Follicle Exclusion of CD8+ T Cells Make Lymph Nodes Sanctuaries of HIV Replication?
por: Beck, Sarah E., et al.
Publicado: (2019)

Comparable antiviral capacity but favorable in vitro survival of CD8s from elite controllers compared to untreated progressors
por: Shasha, D, et al.
Publicado: (2012)

Omic Technologies in HIV: Searching Transcriptional Signatures Involved in Long-Term Non-Progressor and HIV Controller Phenotypes
por: De La Torre-Tarazona, Erick, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4e8466bgplnv97danla5rfbjhp